Innova Captab Limited has officially released its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms that the company has remained in full compliance with all relevant corporate governance standards and procedural requirements throughout the year. The certification, provided by an independent Practicing Company Secretary, underscores the company’s commitment to maintaining high standards of transparency, regulatory adherence, and operational integrity for all its stakeholders.
Commitment to Corporate Governance
Innova Captab Limited has successfully concluded the audit for the financial year ending March 31, 2026, confirming full adherence to its corporate governance obligations. This annual review serves as a testament to the company’s rigorous internal processes and its dedication to maintaining ethical business practices in line with established industry standards.
Key Compliance Findings
The independent review conducted by Jaspreet Dhawan & Associates covered a comprehensive range of corporate requirements, including:
- Policy Adherence: All company policies have been timely updated and approved by the Board of Directors.
- Website Maintenance: The company maintains a fully functional and transparent website providing requisite information to the public.
- Material Subsidiaries: The firm has identified its material subsidiaries, Univentis Medicare Limited and Sharon Bio-Medicine Limited, and maintains proper disclosures regarding their operations.
- Record Preservation: Document management and archival policies remain in full force to ensure organizational transparency.
- Performance Evaluation: The Board of Directors and independent committee members underwent formal performance evaluations during the fiscal year.
Operational Integrity
The report highlights that the company has faced no adverse actions from market regulators or stock exchanges during the fiscal year. Furthermore, the company has effectively managed all Related Party Transactions through the mandatory approval of its Audit Committee, ensuring that all financial dealings are conducted on an arm’s length basis. These results reinforce the company’s robust framework for oversight and its stable growth trajectory as it enters the new financial year.
Source: BSE
